← Back to directory

Hanneke Schuitemaker

Researcher Next ID · RN-010997

Researcher · Immunology and Microbiology

Johnson & Johnson (Israel)

, Israel

Not currently recruitingFunding unknown
Works count
441
Citation count
30,836
H-index
88
i10-index
294

Research interests

Immunology and Microbiology
Medicine
HIV Research and Treatment
HIV/AIDS drug development and treatment
Immune Cell Function and Interaction
HIV/AIDS Research and Interventions
SARS-CoV-2 and COVID-19 Research

Publications

  • Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19

    New England Journal of Medicine · 2021 · 10.1056/nejmoa2101544

  • Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine

    New England Journal of Medicine · 2021 · 10.1056/nejmoa2034201

  • Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques

    Nature · 2020 · 10.1038/s41586-020-2607-z

  • A new classification for HIV-1

    Nature · 1998 · 10.1038/34571

  • Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population

    Journal of Virology · 1992 · 10.1128/jvi.66.3.1354-1360.1992

Current projects

    No projects listed.